HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats.


BACKGROUND An inflammatory process may be one of the critical factors that contribute to the development of diabetic nephropathy (DN). We reported previously that intercellular adhesion molecule-1 (ICAM-1) is up-regulated and promotes macrophage infiltration in the glomeruli of diabetic rats. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase… (More)


6 Figures and Tables